Pilot study of nivolumab in pediatric patients with hypermutant cancers.

Authors: Morgenstern, Daniel A., Collins, Natalie Bucheimer, Deyell, Rebecca, Dvir, Rina, Edwards, Melissa, Faure-Conter, Cecile, Hassall, Timothy E., Sambira, Lauren, Taylor, Emily L., Tabori, Uri, Bouffet, Eric

Source: Journal of clinical oncology. 39(15 suppl):10011-10011

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173225856.0x000001&indx=1&recIds=ETOCvdc_100173225856.0x000001

IMMU-18. FAVORABLE OUTCOME IN REPLICATION REPAIR DEFICIENT HYPERMUTANT BRAIN TUMORS TO IMMUNE CHECKPOINT INHIBITION: AN INTERNATIONAL RRD CONSORTIUM REGISTRY STUDY

Authors: Bouffet, Eric, Sudhaman, Sumedha, Chung, Jiil, Kelly, Jacalyn, Coblentz, Ailish, Edwards, Melissa, Lipman, Tatiana, Zhang, Cindy, Ercan, Ayse Bahar, Sambira, Lauren, Bendel, Anne, Bielack, Stefan, Koustenis, Elisabeth, Blumenthal, Deborah, Bowers, Daniel, Broniscer, Alberto, Bronsema, Annika, Carroll, Sara, Chiaravalli, Stefano, Cole, Kristina, Constantini, Shlomi, De Mola, Rebecca Loret, Dunn, Gavin, Fröjd, Charlotta, Gass, David, Gauvain, Karen, George, Ben, Hijiya, Nobuko, Hoffman, Lindsey, Knipstein, Jeffrey, Laetsch, Ted, Larouche, Valérie, Lassaletta, Alvaro, Lindhorst, Scott, Lossos, Alexander, Luna-Fineman, Sandra, Magimairajan, Vanan, Mason, Gary, Mason, Warren, Massimino, Maura, Mordechai, Oz, Opocher, Enrico, Oren, Michal, Osborn, Michael, Reddy, Alyssa, Remke, Mark, Roy, Sumita, Sabel, Magnus, Samuel, David, Schneider, Kami, Sen, Santanu, Stearns, Duncan, Sumerauer, David, Thomas, Gregory, Tomboc, Patrick, Van Damme, An, Wierman, Margaret, Winer, Ira, Yen, Lee Yi, Zapotocky, Michal, Ziegler, David, Zimmermann, Stefanie, Dvir, Rina, Rechavi, Gidi, Durno, Carol, Aronson, Melyssa, Taylor, Michael, Dirks, Peter, Pugh, Trevor, Shlien, Adam, Hawkins, Cynthia, Morgenstern, Daniel, Tabori, Uri

Source: Neuro-oncology. 22(Supplement 3):iii363-iii363

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100112160275.0x000001&indx=1&recIds=ETOCvdc_100112160275.0x000001

IMMU-20. IMMUNE AND TUMOR BIOMARKERS OF OUTCOME IN REPLICATION REPAIR DEFICIENT BRAIN TUMORS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: UPDATES FROM THE INTERNATIONAL REPLICATION REPAIR DEFICIENCY CONSORTIUM.

Authors: Bouffet, Eric, Sudhaman, Sumedha, Chung, Jiil, Campbell, Brittany, Kelly, Jacalyn, Coblentz, Ailish, Edwards, Melissa, Lipman, Tatiana, Zhang, Cindy, Ercan, Ayse Bahar, Sambira, Lauren, Bendel, Anne, Bielack, Stefan, Koustenis, Elisabeth, Blumenthal, Deborah, Bowers, Daniel, Nichols, Kim, Bronsema, Annika, Carroll, Sara, Chiaravalli, Stefano

Source: Neuro-Oncology; 2019 Supplement, Vol. 21, pii96-ii97, 2p